A real-world study and network pharmacology analysis of EGFR-TKIs combined with ZLJT to delay drug resistance in advanced lung adenocarcinoma
This study aimed to explore the efficacy and safety of combining epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) with ZiLongJin Tablet (ZLJT) in delaying acquired resistance in advanced...
Source: BMC Complementary and Alternative Medicine - Category: Complementary Medicine Authors: Xue Han, Lan Liang, Chenming He, Qinyou Ren, Jialin Su, Liang Cao and Jin Zheng Tags: Research Source Type: research